RESUMO
Actinomycetes isolated from Iran soil habitats were tested for the capacity to produce compounds which can protect neurons from cell death generated by oxidative stress in NT2 neurons. Confirmation of our initial hit was accomplished via the determination of amyloid beta level using the enzyme-linked immunosorbent assay test. The most interesting amyloid beta formation inhibitor discovered in our study was a secondary metabolite which was produced by strain HM45. This bioactive strain was identified as a strain of Streptomyces antibioticus DSM 40234 using polyphasic approach. The strain HM45 was deposited in Deutsche Sammlung von Mikroorganismen und Zellkulturen as S. antibioticus DSM 41955 and University of Tehran Microorganisms Sollection as S. antibioticus UTMC 00105. This work is the first report on efficiency of an actinomycete metabolite in prohibition of neurons death caused by amyloid beta formation.
Assuntos
Peptídeos beta-Amiloides/metabolismo , Neurônios/metabolismo , Estresse Oxidativo , Fragmentos de Peptídeos/metabolismo , Streptomyces antibioticus/metabolismo , Morte Celular , Linhagem Celular Tumoral , Ensaio de Imunoadsorção Enzimática , Genes Bacterianos , Genes de RNAr , Humanos , Irã (Geográfico) , Neurônios/citologia , Filogenia , Microbiologia do Solo , Streptomyces antibioticus/classificação , Streptomyces antibioticus/genética , Streptomyces antibioticus/isolamento & purificaçãoRESUMO
Two novel angucyclinone-type antibiotics, simocyclinones D4 and D8, were detected in the mycelium extract of Streptomyces antibioticus Tü 6040 by HPLC-diode-array and HPLC-electrospray-mass-spectrometry screening. The compounds show antibiotic activities against Gram-positive bacteria and cytostatic effects on various tumor cell lines.